Does the form of venous thromboembolism prophylaxis following primary total knee arthroplasty alter the rate of early reoperation or revision surgery?
David L KerrStephen ButlerAndrew C ReadIan A HarrisPublished in: ANZ journal of surgery (2019)
There was a higher rate of reoperation in patients treated with aspirin following TKA when compared to enoxaparin and rivaroxaban in the perioperative period. While there is extensive data on the safety and efficacy of these medications following joint arthroplasty, improved reporting of surgically relevant outcomes are needed to assist both the surgeon and patient in clinical decision-making.
Keyphrases
- total knee arthroplasty
- venous thromboembolism
- total hip
- decision making
- direct oral anticoagulants
- minimally invasive
- low dose
- coronary artery bypass
- patients undergoing
- cardiac surgery
- electronic health record
- adverse drug
- cardiovascular events
- robot assisted
- metabolic syndrome
- surgical site infection
- machine learning
- type diabetes
- skeletal muscle
- glycemic control
- adipose tissue
- antiplatelet therapy
- insulin resistance
- deep learning
- atrial fibrillation
- acute kidney injury